Sample Quality Control For Nucleic Acid-Based Vaccine Development

Automated electrophoresis such as the Agilent Fragment Analyzer and TapeStation systems, provide reliable nucleic acid sample quality control which is important for DNA and RNA-based biotherapeutics such as IVT mRNA vaccines. This brochure highlights the critical role of precise and reliable sample analysis in the development of effective vaccines.

Key features include:

• Automated Electrophoresis Technology: Learn about Agilent's automated electrophoresis systems that aid in the analysis process to reduce manual intervention and minimize errors.
• Enhanced Workflow Efficiency: Discover how Agilent's solutions streamline the workflow, from sample preparation to data analysis, significantly improving throughput and consistency.
• Quality Control and Assurance: Explore how Agilent's electrophoresis systems support stringent quality control measures, ensuring that vaccine candidates meet regulatory standards.

Access the full brochure to see how Agilent's automated electrophoresis solutions can enhance your sample quality control processes.